Dr. Giammaria Sara
Research line: Glaucoma and anterior segment with ocular annexes
Research unit: RU Glaucoma
Simple Operating Unit: Simple Operating Unit Glaucoma and Hospital-Territory Integration
Main specializations: GLAUCOMA
Medical activity: Works at IRCCS G.B. Bietti in the offices Via Livenza, 3 and Via di santo Stefano Rotondo 6, at Presidio Ospedaliero Britannico, Rome.
Scientific publication: Pubmed
- In 2016, Degree in Medicine at University of Rome Tor Vergata (110/110 cum laude)
- In 2020, Ophthalmology residency at University of Rome Tor Vergata (50/50 cum laude)
- From 2020 to 2022, Glaucoma Research Fellowship at the Department of Visual Sciences and Ophthalmology of Dalhousie University in Halifax (Canada), with Prof. Balwantray Chauhan.
- From 2021 to present, PhD in “Tissue Engineering and remodeling Biotechnologies for body function”, University of Rome Tor Vergata.
Since 2022, Glaucoma Unit Researcher at IRCCS-Fondazione GB Bietti, Rome, Italy
- Member of Società Oftalmologica Italiana (SOI)
- Member of Associazione Italiana Studio del Glaucoma (AISG)
- Member of European Glaucoma Society (EGS)
- Sub Investigator in an interventional multi-center clinical trial, started in 2018 and concerning quality of life, entitled: “Effect of Neurotidine® (Citicoline Free Acid in Oral Solution) on Quality of Life in Patients With Glaucoma”. gov Identifier:NCT04046809
- Sub Investigator in an interventional multi-center clinical trial concerning glaucoma therapy, entitled: “A phase III, multinational, multicenter, investigator-masked, randomised, active-controlled trial, comparing the efficacy and safety of DE-130A with Xalatan® in patients with open-angle glaucoma or ocular hypertension over a 3-month period, followed by a 12-month follow-up with open-label DE-130A treatment”. ClinicalTrials.gov Identifier: NCT04133311
- Reviewer for “Translational vision science & technology” and “Investigative Ophthalmology and Visual Science”
